Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor
Authors
Keywords
Gastrointestinal stromal tumor, Imatinib, Single-nucleotide polymorphism, <em class=EmphasisTypeItalic >ABCG2</em>, Prognosis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 75, Issue 1, Pages 173-182
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1007/s00280-014-2630-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction
- (2013) Y. Shinohara et al. HAEMATOLOGICA
- Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors
- (2013) Changhoon Yoo et al. INVESTIGATIONAL NEW DRUGS
- Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
- (2012) S. J. Seong et al. ANNALS OF ONCOLOGY
- Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
- (2012) Amina Haouala et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients
- (2012) K. Eechoute et al. CLINICAL CANCER RESEARCH
- Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study
- (2011) Hye Jin Kang et al. ACTA ONCOLOGICA
- Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells
- (2011) Petr Mlejnek et al. ANNALS OF HEMATOLOGY
- ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
- (2011) Robert W. Robey et al. Anti-Cancer Agents in Medicinal Chemistry
- Molecular Targeted Therapy of Gastrointestinal Stromal Tumors
- (2011) P. Reichardt et al. CURRENT CANCER DRUG TARGETS
- The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor
- (2010) Alessandro Gronchi et al. CANCER
- Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor
- (2010) Wei-Lien Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Drug Transporters and Imatinib Treatment: Implications for Clinical Practice
- (2010) K. Eechoute et al. CLINICAL CANCER RESEARCH
- Breast Cancer Resistance Protein (BCRP)-Mediated Glyburide Transport: Effect of the C421A/Q141K BCRP Single-Nucleotide Polymorphism
- (2010) E. K. Pollex et al. DRUG METABOLISM AND DISPOSITION
- Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia
- (2010) Naoto Takahashi et al. JOURNAL OF HUMAN GENETICS
- Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
- (2010) Ling-Na Ni et al. MEDICAL ONCOLOGY
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
- (2009) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor
- (2009) Min-Hee Ryu et al. ONCOLOGY
- Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability
- (2008) N Widmer et al. BRITISH JOURNAL OF CANCER
- The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
- (2008) Roos L. Oostendorp et al. INVESTIGATIONAL NEW DRUGS
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now